A phosphorylation-related variant ADD1-rs4963 modifies the risk of colorectal cancer.
about
Molecular Genetics External Quality Assessment Pilot Scheme for Irinotecan-Related UGT1A1 Genotyping in China.Adducin in tumorigenesis and metastasis.TRAP1 regulates stemness through Wnt/β-catenin pathway in human colorectal carcinomaA Review on Adducin from Functional to Pathological Mechanisms: Future Direction in Cancer.
P2860
A phosphorylation-related variant ADD1-rs4963 modifies the risk of colorectal cancer.
description
2015 nî lūn-bûn
@nan
2015 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի մարտին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
name
A phosphorylation-related variant ADD1-rs4963 modifies the risk of colorectal cancer.
@ast
A phosphorylation-related variant ADD1-rs4963 modifies the risk of colorectal cancer.
@en
type
label
A phosphorylation-related variant ADD1-rs4963 modifies the risk of colorectal cancer.
@ast
A phosphorylation-related variant ADD1-rs4963 modifies the risk of colorectal cancer.
@en
prefLabel
A phosphorylation-related variant ADD1-rs4963 modifies the risk of colorectal cancer.
@ast
A phosphorylation-related variant ADD1-rs4963 modifies the risk of colorectal cancer.
@en
P2093
P2860
P1433
P1476
A phosphorylation-related variant ADD1-rs4963 modifies the risk of colorectal cancer.
@en
P2093
Jiaoyuan Li
Liming Cheng
Rong Zhong
Xiaoping Miao
Xueqin Chen
Yajie Gong
P2860
P304
P356
10.1371/JOURNAL.PONE.0121485
P407
P577
2015-03-27T00:00:00Z